Euticals S.p.A.

Also on record

Records under this name other than the patents Euticals S.p.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Euticals S.p.A.

Patent	Title	Status	Expires	Confidence
US 8,357,675	17-alpha-substituted derivatives of estradiol with wound-healing activity Formerly held In force Term ends Jun 1, 2028 · From the USPTO record	In force	Term ends Jun 1, 2028	From the USPTO record
US 8,729,308	Process for the preparation of tapentadol and intermediates thereof Formerly held In force Term ends Nov 30, 2030 · From the USPTO record	In force	Term ends Nov 30, 2030	From the USPTO record
US 8,791,287	Process for the synthesis of tapentadol and intermediates thereof Formerly held In force Term ends Jun 20, 2031 · From the USPTO record	In force	Term ends Jun 20, 2031	From the USPTO record
US 9,169,269	Water-soluble solid pharmaceutical inclusion complexes and their aqueous solutions for oral, ophthalmic, topical or parenteral use containing a macrolide and certain cyclodextrins Formerly held In force Term ends Mar 22, 2032 · From the USPTO record	In force	Term ends Mar 22, 2032	From the USPTO record
US 9,738,663	Process for the preparation of aminoaryl- and aminoheteroaryl boronic acids and esters Formerly held In force Term ends Apr 30, 2034 · From the USPTO record	In force	Term ends Apr 30, 2034	From the USPTO record
US 10,196,406	Process for the preparation of aminoaryl- and aminoheteroaryl boronic acids and esters Formerly held In force Term ends Apr 30, 2034 · From the USPTO record	In force	Term ends Apr 30, 2034	From the USPTO record
US 9,102,689	Process for the Preparation of Boronic Acid Intermediates Formerly held In force Term ends May 5, 2034 · High confidence	In force	Term ends May 5, 2034	High confidence
US 9,630,923	Biocatalyzed synthesis of the optically pure (R) and (S) 3-methyl-1,2,3,4-tetrahydroquinoline and their use as chiral synthons for the preparation of the antithrombic (21R)- and (21S)-argatroban Formerly held In force Term ends Jul 4, 2034 · From the USPTO record	In force	Term ends Jul 4, 2034	From the USPTO record
US 10,144,756	Stable solid forms of regadenoson Formerly held In force Term ends Nov 16, 2034 · From the USPTO record	In force	Term ends Nov 16, 2034	From the USPTO record
US 9,765,082	Crystalline form of tiotropium bromide with lactose Formerly held In force Term ends Feb 26, 2035 · From the USPTO record	In force	Term ends Feb 26, 2035	From the USPTO record

10 of 35 patents shown.

Pro members see all 35.

Pro members: see all 35 patents